Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 115
- +11 vs. Q1 2026
- Portfolio value
- $1.83B
- +$316.9M (+20.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 287,668 | $155.9M | 8.5% | +23,397+8.9% | Added | History |
| ABVXAbivax S.A. | SPONSORED ADS | 913,880 | $121.8M | 6.6% | −20,543−2.2% | Reduced | History |
| EHCEncompass Health Corp | COM | 1,026,919 | $103.8M | 5.7% | +832,815+429.1% | Added | History |
| ENSGEnsign Group, Inc | COM | 602,079 | $96.5M | 5.3% | +587,318+3,978.8% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 2,212,770 | $94.9M | 5.2% | +39,484+1.8% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,785,941 | $66.5M | 3.6% | −2,075−0.1% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,798,210 | $61.2M | 3.3% | −87,412−3.0% | Reduced | History |
| BKDBrookdale Senior Living Inc. | COM | 3,396,470 | $54.6M | 3.0% | −172,085−4.8% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 664,684 | $52.7M | 2.9% | +32,584+5.2% | Added | History |
| NTRANatera, Inc. | COM | 175,807 | $47.7M | 2.6% | −208,906−54.3% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 798,973 | $45.4M | 2.5% | +256,363+47.2% | Added | History |
| CTRECareTrust REIT, Inc. | COM | 1,072,015 | $43.3M | 2.4% | +1,072,015 | New | History |
| HCAHCA Healthcare, Inc. | COM | 98,252 | $38.3M | 2.1% | +19,023+24.0% | Added | History |
| PCVXVaxcyte, Inc. | COM | 629,952 | $36.6M | 2.0% | −294,241−31.8% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 428,652 | $34.2M | 1.9% | −248,740−36.7% | Reduced | History |
| CYHCommunity Health Systems Inc | COM | 7,864,575 | $26.3M | 1.4% | −812,706−9.4% | Reduced | History |
| GSKGSK plc | ADR | 481,833 | $25.3M | 1.4% | −1,303,342−73.0% | Reduced | History |
| CHEChemed Corp | COM | 52,523 | $24.5M | 1.3% | +21,466+69.1% | Added | History |
| LLYEli Lilly & Co | Stock | 20,116 | $24.1M | 1.3% | +1,116+5.9% | Added | History |
| GERNGeron Corp | COM | 18,717,422 | $24.0M | 1.3% | −117,461−0.6% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 602,922 | $23.5M | 1.3% | +363,812+152.2% | Added | History |
| OHIOmega Healthcare Investors Inc | COM | 483,547 | $23.1M | 1.3% | −102,133−17.4% | Reduced | History |
| PODDInsulet Corp | Stock | 148,816 | $22.7M | 1.2% | +5,270+3.7% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 114,199 | $21.4M | 1.2% | +84,687+287.0% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 51,145 | $21.3M | 1.2% | +51,145 | New | History |
| WELLWelltower Inc. | REIT | 87,312 | $19.8M | 1.1% | −93,641−51.7% | Reduced | History |
| BBNXBeta Bionics, Inc. | COM | 1,249,441 | $19.6M | 1.1% | −165,397−11.7% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 490,235 | $19.0M | 1.0% | +490,235 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,865,653 | $18.7M | 1.0% | −1,174,167−38.6% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 80,594 | $18.4M | 1.0% | +47,783+145.6% | Added | History |
| PNTGPennant Group, Inc. | COM | 460,272 | $17.0M | 0.9% | +148,094+47.4% | Added | History |
| LTCLTC Properties Inc | REIT | 420,640 | $16.2M | 0.9% | +99,594+31.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 149,209 | $15.9M | 0.9% | +149,209 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 831,142 | $15.3M | 0.8% | +117,873+16.5% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 249,607 | $14.3M | 0.8% | +41,839+20.1% | Added | History |
| AMNAmn Healthcare Services Inc | COM | 428,531 | $13.9M | 0.8% | +428,531 | New | History |
| CELCCelcuity Inc. | COM | 127,931 | $13.4M | 0.7% | +127,931 | New | History |
| PHVSPharvaris N.V. | COM | 386,383 | $13.4M | 0.7% | −20,577−5.1% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,558,497 | $13.3M | 0.7% | +369,983+11.6% | Added | History |
| HUMHumana Inc | Stock | 31,171 | $12.4M | 0.7% | +31,171 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 196,532 | $11.9M | 0.6% | +66,958+51.7% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 747,994 | $11.2M | 0.6% | +747,994 | New | History |
| ASNDAscendis Pharma A/S | ORD SHS | 41,621 | $11.1M | 0.6% | +41,621 | New | History |
| BRKRBruker Corp | COM | 182,894 | $11.0M | 0.6% | +65,881+56.3% | Added | History |
| MRNAModerna, Inc. | Stock | 152,122 | $10.7M | 0.6% | −7,586−4.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 196,302 | $10.5M | 0.6% | +58,266+42.2% | Added | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 217,185 | $10.2M | 0.6% | +56,462+35.1% | Added | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 672,825 | $9.52M | 0.5% | −5,099−0.8% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,471 | $9.34M | 0.5% | −10,293−3.6% | Reduced | History |
| RVTYRevvity, Inc. | COM | 83,624 | $9.30M | 0.5% | −1,230−1.4% | Reduced | History |
| PALIPalisade Bio, Inc. | COM | 4,182,785 | $8.74M | 0.5% | −804,714−16.1% | Reduced | History |
| ARDXArdelyx, Inc. | COM | 1,678,345 | $8.56M | 0.5% | −551,101−24.7% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 309,689 | $8.36M | 0.5% | +309,689 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 434,314 | $8.13M | 0.4% | +163,609+60.4% | Added | History |
| NVONovo Nordisk A S | ADR | 169,227 | $8.11M | 0.4% | +169,227 | New | History |
| BHVNBiohaven Ltd. | COM | 515,804 | $7.68M | 0.4% | +515,804 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 58,504 | $7.17M | 0.4% | +58,504 | New | History |
| ELVNEnliven Therapeutics, Inc. | COM | 136,631 | $6.93M | 0.4% | +136,631 | New | History |
| REPLReplimune Group, Inc. | COM | 590,252 | $6.53M | 0.4% | +255,391+76.3% | Added | History |
| LBRXLB Pharmaceuticals Inc | COM SHS | 183,663 | $5.96M | 0.3% | +83,465+83.3% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 166,289 | $5.71M | 0.3% | +166,289 | New | History |
| NHINational Health Investors Inc | COM | 70,673 | $5.39M | 0.3% | +70,673 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,130 | $5.15M | 0.3% | +91,555+146.3% | Added | History |
| PACSPACS Group, Inc. | COM SHS | 117,441 | $5.01M | 0.3% | +117,441 | New | History |
| EQEquillium, Inc. | COM | 1,520,824 | $4.87M | 0.3% | +21,831+1.5% | Added | History |
| ANABAnaptysbio, Inc | COM | 69,983 | $4.72M | 0.3% | +42,894+158.3% | Added | History |
| NHCNational Healthcare Corp | COM | 22,116 | $4.67M | 0.3% | +22,116 | New | History |
| EYPTEyePoint, Inc. | COM NEW | 297,735 | $4.26M | 0.2% | +297,735 | New | History |
| SNDASonida Senior Living, Inc. | COM | 102,624 | $4.19M | 0.2% | +74,187+260.9% | Added | History |
| GKOSGLAUKOS Corp | COM | 29,343 | $4.10M | 0.2% | −30,871−51.3% | Reduced | History |
| AGLagilon health, inc. | COM NEW | 37,792 | $4.05M | 0.2% | −138,796−78.6% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 135,355 | $3.55M | 0.2% | −441,225−76.5% | Reduced | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 55,710 | $3.51M | 0.2% | +55,710 | New | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 128,286 | $3.39M | 0.2% | +3,118+2.5% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 377,007 | $3.02M | 0.2% | +240,772+176.7% | Added | History |
| IFRXInflaRx N.V. | COM | 1,304,069 | $2.92M | 0.2% | −454,504−25.8% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 7,241 | $2.88M | 0.2% | −3,878−34.9% | Reduced | History |
| ALECAlector, Inc. | COM | 1,423,873 | $2.86M | 0.2% | +72,767+5.4% | Added | History |
| VORVor Biopharma Inc. | COM NEW | 149,681 | $2.76M | 0.2% | +149,681 | New | History |
| DSGNDesign Therapeutics, Inc. | COM | 190,000 | $2.75M | 0.1% | +190,000 | New | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 276,174 | $2.70M | 0.1% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 1,890,904 | $2.53M | 0.1% | −457,456−19.5% | Reduced | History |
| CTNMContineum Therapeutics, Inc. | CL A | 148,017 | $2.43M | 0.1% | +1,606+1.1% | Added | History |
| EVMNEvommune, Inc. | COM SHS | 174,460 | $2.32M | 0.1% | +119,780+219.1% | Added | History |
| AMRNAmarin Corp PLC | SPONSORED ADR | 145,296 | $2.32M | 0.1% | −2,419−1.6% | Reduced | History |
| SPRBSpruce Biosciences, Inc. | COM NEW | 40,000 | $2.16M | 0.1% | +40,000 | New | History |
| RGENRepligen Corp | COM | 14,401 | $1.96M | 0.1% | −106,384−88.1% | Reduced | History |
| IVVDInvivyd, Inc. | COM | 2,237,015 | $1.95M | 0.1% | −39,334−1.7% | Reduced | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 1,022,265 | $1.90M | 0.1% | +1,022,265 | New | History |
| GRCEGrace Therapeutics, Inc. | CL A | 772,900 | $1.75M | 0.1% | +16,300+2.2% | Added | History |
| AVRAnteris Technologies Global Corp. | COM | 166,229 | $1.64M | 0.1% | −234,958−58.6% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 156,636 | $1.60M | 0.1% | −93,364−37.3% | Reduced | History |
| EDITEditas Medicine, Inc. | COM | 458,809 | $1.49M | 0.1% | +167,890+57.7% | Added | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 303,306 | $1.39M | 0.1% | −3,494−1.1% | Reduced | History |
| TECHBIO-TECHNE Corp | COM | 19,308 | $1.36M | 0.1% | −106,588−84.7% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 6,943 | $1.30M | 0.1% | +6,943 | New | History |
| SVRASavara Inc | COM | 204,428 | $1.26M | 0.1% | −179,836−46.8% | Reduced | History |
| SRZNSurrozen, Inc. | COM NEW | 47,777 | $1.24M | 0.1% | −10,847−18.5% | Reduced | History |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 1,035,360 | $1.14M | 0.1% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 891,425 | $1.02M | 0.1% | 00.0% | Unchanged | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2026 (20)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| DOCHealthpeak Properties, Inc. | COM | 1,981,070 | $32.5M | 2.1% | History |
| AVTRAvantor, Inc. | COM | 2,974,287 | $23.3M | 1.5% | History |
| QGENQiagen N.V. | ORD SHARES | 545,330 | $21.8M | 1.4% | History |
| ICLRIcon PLC | COM | 68,688 | $7.60M | 0.5% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 200,000 | $6.77M | 0.4% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 10,000 | $5.23M | 0.3% | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,735,963 | $4.76M | 0.3% | History |
| HQYHealthequity, Inc. | COM | 51,614 | $4.31M | 0.3% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 183,902 | $3.94M | 0.3% | History |
| CNCCentene Corp | Stock | 111,652 | $3.66M | 0.2% | History |
| EHABEnhabit, Inc. | COM | 227,451 | $3.20M | 0.2% | History |
| STROSutro Biopharma, Inc. | COM SHS | 73,161 | $1.82M | 0.1% | History |
| NVCRNovoCure Ltd | ORD SHS | 134,917 | $1.47M | 0.1% | History |
| BVSBioventus Inc. | COM CL A | 159,110 | $1.45M | 0.1% | History |
| IMCRImmunocore Holdings plc | ADS | 39,238 | $1.18M | 0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 27,055 | $1.04M | 0.1% | History |
| PASGPassage BIO, Inc. | COM | 131,581 | $1.03M | 0.1% | History |
| DHCDiversified Healthcare Trust | COM SH BEN INT | 151,283 | $1.00M | 0.1% | History |
| INMDInMode Ltd. | SHS | 67,744 | $926.7K | 0.1% | History |
| AIRSAirsculpt Technologies, Inc. | COM | 74,139 | $209.8K | <0.1% | History |